Bis-dihydroisoxazolines: Synthesis, Structural Elucidation, Antimicrobial Evaluation, and DNA Photocleavage Assay

Author(s): Manvinder Kaur, Mohamad Yusuf, Dharambeer Singh Malhi, Harvinder Singh Sohal*

Journal Name: Current Organic Synthesis

Volume 17 , Issue 8 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Aim and objective: Isoxazole is an active core found in many drugs. The aim of this work was to synthesize bis-isoxazoline compounds and to analyze the effect of linker chain length on biological activities.

Material and Methods: A simple, convenient, and efficient method for the conversion of bischalcones to new bis(4,5-dihydroisoxazole) derivatives was developed by using hydroxylamine hydrochloride under basic medium. Synthesized moieties were also evaluated for their antimicrobial potencies and DNA photocleavage assay.

Results and Discussion: The synthesized compounds were more active than their chalcone precursors and the long-chain linkers (4e&4f) were more potent in antimicrobial, as well as in DNA photocleavage activity.

Conclusion: It was found that many of the tested bischalcones and bis-isoxazolines exhibited moderate to significant antimicrobial activity against various strains. Furthermore, the present study also provides significant information and interesting outcomes regarding cyclization, increasing the length of linker chains, and their effects on the DNA photocleavage and antimicrobial activities.

Keywords: DNA photocleavage assay, plasmid DNA, antimicrobial activity, bischalcones, bisisoxazolines, linkers.

[1]
Kang, Y.K.; Shin, K.J.; Yoo, K.H.; Seo, K.J.; Hong, C.Y.; Lee, C.S.; Park, S.Y.; Kim, D.J.; Park, S.W. Synthesis and antibacterial activity of new carbapenems containing isoxazole moiety. Bioorg. Med. Chem. Lett., 2000, 10(2), 95-99.
[http://dx.doi.org/10.1016/S0960-894X(99)00646-0] [PMID: PMID: 10673088]
[2]
Agrawal, N.; Mishra, P. The synthetic and therapeutic expedition of isoxazole and its analogs. Med. Chem. Res., 2018, 27(5), 1309-1344.
[http://dx.doi.org/10.1007/s00044-018-2152-6] [PMID: PMID: 32214770]
[3]
Sadashiva, M.P. Basappa; NanjundaSwamy, S.; Li, F.; Manu, K.A.; Sengottuvelan, M.; Prasanna, D.S.; Anilkumar, N.C.; Sethi, G.; Sugahara, K.; Rangappa, K.S. Anti-cancer activity of novel dibenzo[b,f]azepine tethered isoxazoline derivatives. BMC Chem. Biol., 2012, 12, 5-12.
[http://dx.doi.org/10.1186/1472-6769-12-5] [PMID: PMID: 23033888]
[4]
Gordaliza, M.; Castro, M.; del Corral, J.M.; López-Vázquez, M.; García, P.A.; San Feliciano, A.; García-Grávalos, M.; Broughton, H. Preparation and cytotoxicity of podophyllotoxin derivatives lacking the lactone ring. Tetrahedron, 1997, 53, 15743-15760.
[http://dx.doi.org/10.1016/S0040-4020(97)10042-4]
[5]
Gaonkar, S.L.; Rai, K.L.; Prabhuswamy, B. Synthesis of novel 3-[5-ethyl-2-(2-phenoxy-ethyl)-pyridin]-5-substituted isoxazoline libraries via 1, 3-dipolar cycloaddition and evaluation of antimicrobial activities. Med. Chem. Res., 2007, 15, 407-417.
[http://dx.doi.org/10.1007/s00044-006-0015-z]
[6]
Patil, D.; Chincholkar, M.M.; Dighade, N.R. antibacterial and antifungal activity of 3-(2-hydroxy-5-methylphenyl)-5,5-dialkyl/5,5-diaryl/5-aryl/4-aroyl-5-aryl-isoxazolines. Asian J. Chem., 2003, 15, 450-459.
[7]
Kedar, R.M.; Vidhale, N.N.; Chincholkar, M.M. Synthesis of new heterocycles and their antimicrobial study. Orient. J. Chem., 1997, 13, 143-148.
[8]
Vikani, H.J.; Patel, P.H.; Parekh, H.H. Studies on Isoxazoline derivatives: 3-Methyl 4 (2′-Triazoloanilido)-5-Aryl-Isoxazolines. J. Inst. Chem., 1996, 68, 21-22.
[9]
Guguloth, V.; Paidakula, S.; Vadde, R. One-pot regioselective synthesis of some novel isoxazole-phenothiazine hybrids and their antibacterial activity. Russ. J. Gen. Chem., 2020, 90, 470-475.
[http://dx.doi.org/10.1134/S1070363220030214]
[10]
Tiwari, N.; Dwivedi, B. Nizamuddin, Synthesis of some pyrazoline and isoxazolin derivatives as possible fungicides. Boll. Chim. Farm., 1989, 128(11), 332-335.
[11]
Barot, V.M.; Modi, S.R.; Naik, H.B. Synthesis of 2, 4-diaryl-2, 3-dihydro-1, 5-benzo-thiazepines as antibacterial agents. Orient. J. Chem., 2000, 16, 569-570.
[12]
Khan, M.S.Y.; Bawa, S. Syntheses and antiinflammatory activity of new α-pyronochalcones, α-pyronoflavones and related products from 8-acetylumbelliferone. Indian J. Chem., 2001, B40, 1207-1214.
[13]
Shivkumar, B.; Nargund, L.V.G. Synthesis, characterization and anti-inflammatory activity of some isoxazoline derivatives. Inian. J. Heterocy. Ch., 1998, 8, 27-33.
[14]
Habeeb, A.G.; Praveen Rao, P.N.; Knaus, E.E. Design and synthesis of 4,5-diphenyl-4-isoxazolines: novel inhibitors of cyclooxygenase-2 with analgesic and antiinflammatory activity. J. Med. Chem., 2001, 44(18), 2921-2927.
[http://dx.doi.org/10.1021/jm0101287] [PMID: PMID: 11520200]
[15]
Lahm, G.P.; Cordova, D.; Barry, J.D.; Pahutski, T.F.; Smith, B.K.; Long, J.K.; Benner, E.A.; Holyoke, C.W.; Joraski, K.; Xu, M.; Schroeder, M.E.; Wagerle, T.; Mahaffey, M.J.; Smith, R.M.; Tong, M.H. 4-Azolylphenyl isoxazoline insecticides acting at the GABA gated chloride channel. Bioorg. Med. Chem. Lett., 2013, 23(10), 3001-3006.
[http://dx.doi.org/10.1016/j.bmcl.2013.03.031] [PMID: PMID: 23566518]
[16]
Casida, J.E. Golden age of RyR and GABA-R diamide and isoxazoline insecticides: common genesis, serendipity, surprises, selectivity, and safety. Chem. Res. Toxicol., 2015, 28(4), 560-566.
[http://dx.doi.org/10.1021/tx500520w] [PMID: PMID: 25688713]
[17]
Wang, Y.; Shao, Y.; Wang, Y.; Fan, L.; Yu, X.; Zhi, X.; Yang, C.; Qu, H.; Yao, X.; Xu, H. Synthesis and quantitative structure-activity relationship (QSAR) study of novel isoxazoline and oxime derivatives of podophyllotoxin as insecticidal agents. J. Agric. Food Chem., 2012, 60(34), 8435-8443.
[http://dx.doi.org/10.1021/jf303069v] [PMID: PMID: 22891988]
[18]
Zhang, Y.Y.; Gao, S.; Liu, Y.X.; Wang, C.; Jiang, W.; Zhao, L.X.; Fu, Y.; Ye, F. Design, synthesis, and biological activity of novel diazabicyclo derivatives as safeners. J. Agric. Food Chem., 2020, 68(11), 3403-3414.
[http://dx.doi.org/10.1021/acs.jafc.9b07449] [PMID: PMID: 32101688]
[19]
Fu, Y.; Zhang, D.; Zhang, S.Q.; Liu, Y.X.; Guo, Y.Y.; Wang, M.X.; Gao, S.; Zhao, L.X.; Ye, F. Discovery of N-aroyl diketone/triketone derivatives as novel 4-hydroxyphenylpyruvate dioxygenase inhibiting-based herbicides. J. Agric. Food Chem., 2019, 67(43), 11839-11847.
[http://dx.doi.org/10.1021/acs.jafc.9b01412] [PMID: PMID: 31589436]
[20]
Tangallapally, R.P.; Sun, D. Rakesh; Budha, N.; Lee, R.E.; Lenaerts, A.J.; Meibohm, B.; Lee, R.E. Discovery of novel isoxazolines as anti-tuberculosis agents. Bioorg. Med. Chem. Lett., 2007, 17(23), 6638-6642.
[http://dx.doi.org/10.1016/j.bmcl.2007.09.048] [PMID: PMID: 17937983]
[21]
Mandawad, G.G.; Kamble, R.D.; Hese, S.V.; More, R.A.; Gacche, R.N.; Kodam, K.M.; Dawane, B.S. An efficient synthesis of isoxazoline libraries of thiophene analogs and its antimycobacterial investigation. Med. Chem. Res., 2014, 23, 4455-4463.
[http://dx.doi.org/10.1007/s00044-014-1016-y]
[22]
Saeedi, M.; Rastegari, A.; Hariri, R.; Mirfazli, S.S.; Mahdavi, M.; Edraki, N.; Firuzi, O.; Akbarzadeh, T. Design and synthesis of novel arylisoxazole chromenonecarbox-amides: Investigation of biological activities associated with Alzheimer’s disease. Chem. Biodivers., 2020, 17(5)e1900746
[http://dx.doi.org/10.1002/cbdv.201900746] [PMID: PMID: 32154628]
[23]
Srivastava, S.; Bajpai, L.K.; Batra, S.; Bhaduri, A.P.; Maikhuri, J.P.; Gupta, G.; Dhar, J.D. In search of new chemical entities with spermicidal and anti-HIV activities. Bioorg. Med. Chem., 1999, 7(11), 2607-2613.
[http://dx.doi.org/10.1016/S0968-0896(99)00188-1] [PMID: PMID: 10632071]
[24]
Kai, H.; Matsumoto, H.; Hattori, N.; Takase, A.; Fujiwara, T.; Sugimoto, H. Anti-influenza virus activities of 2-alkoxyimino-n-(2-isoxazolin-3-ylmethyl)acetamides. Bioorg. Med. Chem. Lett., 2001, 11(15), 1997-2000.
[http://dx.doi.org/10.1016/S0960-894X(01)00362-6] [PMID: PMID: 11454466]
[25]
Padmaja, A.; Rajasekhar, C.; Durgamma, S.; Venkatesh, B.C.; Padmavathi, V. Synthesis and antioxidant activity of pyrazolyl-oxazolines/thiazolines and isoxazolyl-oxazolines/thiazolines. Med. Chem. Res., 2014, 23, 1084-1098.
[http://dx.doi.org/10.1007/s00044-013-0688-z]
[26]
Dannhardt, G.; Kiefer, W.; Krämer, G.; Maehrlein, S.; Nowe, U.; Fiebich, B. The pyrrole moiety as a template for COX-1/COX-2 inhibitors. Eur. J. Med. Chem., 2000, 35(5), 499-510.
[http://dx.doi.org/10.1016/S0223-5234(00)00150-1] [PMID: PMID: 10889329]
[27]
Chavez, M.L.; DeKorte, C.J. Valdecoxib: A review. Clin. Ther., 2003, 25(3), 817-851.
[http://dx.doi.org/10.1016/S0149-2918(03)80110-8] [PMID: PMID: 12852704]
[28]
Bruning, J.B.; Murillo, A.C.; Chacon, O.; Barletta, R.G.; Sacchettini, J.C. Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine. Antimicrob. Agents Chemother., 2011, 55(1), 291-301.
[http://dx.doi.org/10.1128/AAC.00558-10] [PMID: PMID: 20956591]
[29]
Eckhard, I.F.; Lehtonen, K.; Staub, T.; Summers, L.A. Structure of Acyl Derivatives of the Fungicide Drazoxolon and Related Arylhydrazonoisoxazolones. Aust. J. Chem., 1973, 26, 2705-2710.
[http://dx.doi.org/10.1071/CH9732705]
[30]
Clark, D.G.; McElligott, T.F. Acute and short-term toxicity of drazoxolon (4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone). Food Cosmet. Toxicol., 1969, 7(5), 481-491.
[http://dx.doi.org/10.1016/S0015-6264(69)80428-1] [PMID: PMID: 5351712]
[31]
Peters, D.H.; Sorkin, E.M.; Zonisamide, A. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs, 1993, 45(5), 760-787.
[http://dx.doi.org/10.2165/00003495-199345050-00010] [PMID: PMID: 7686468]
[32]
Kaur, K.; Kumar, V.; Beniwal, V.; Kumar, V.; Aneja, K.R.; Sharma, V.; Jaglan, S. Solvent-free synthesis of novel (E)-2-(3, 5-dimethyl-4-(aryldiazenyl)-1H-pyrazol-1-yl)-4-arylthiazoles: Determination of their biological activity. Med. Chem. Res., 2015, 24, 3863-3875.
[http://dx.doi.org/10.1007/s00044-015-1429-2]
[33]
Olender, D.; Żwawiak, J.; Zaprutko, L. Multidirectional efficacy of biologically active nitro compounds included in medicines. Pharmaceuticals (Basel), 2018, 11(2), 54-82.
[http://dx.doi.org/10.3390/ph11020054] [PMID: PMID: 29844300]
[34]
Nepali, K.; Lee, H.Y.; Liou, J.P. Nitro-group-containing drugs. J. Med. Chem., 2019, 62(6), 2851-2893.
[http://dx.doi.org/10.1021/acs.jmedchem.8b00147] [PMID: PMID: 30295477]
[35]
Yusuf, M.; Kaur, M.; Jain, P.; Solanki, I. New 1,3,4-bisthiadiazolines: synthesis, characterization and antimicrobial evaluations. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2012, 97, 470-478.
[http://dx.doi.org/10.1016/j.saa.2012.06.030] [PMID: PMID: 22832010]
[36]
Yusuf, M.; Kaur, M.; Sohal, H.S. Synthesis, Antimicrobial evaluations, and DNA photo cleavage studies of new bispyranopyrazoles. J. Heterocycl. Chem., 2015, 54, 706-713.
[http://dx.doi.org/10.1002/jhet.2530]
[37]
Ramos, R.R.; da Silva, C.C.; Guimarães, F.F.; Martins, F.T. Polymorphism and conformerism in chalcones. CrystEngComm, 2016, 18, 2144-2154.
[http://dx.doi.org/10.1039/C5CE02591E]
[38]
Gritzapis, P.S.; Varras, P.C.; Andreou, N.P.; Katsani, K.R.; Dafnopoulos, K.; Psomas, G.; Peitsinis, Z.V.; Koumbis, A.E.; Fylaktakidou, K.C. p-Pyridinyl oxime carbamates: Synthesis, DNA binding, DNA photocleaving activity and theoretical photodegradation studies. Beilstein J. Org. Chem., 2020, 16, 337-350.
[http://dx.doi.org/10.3762/bjoc.16.33] [PMID: PMID: 32256851]
[39]
Islam, M.K.; Jackson, P.J.M.; Thurston, D.E.; Rahman, K.M. Methylene-linked bis-phenylbenzimidazoles - A new scaffold to target telomeric DNA/RNA hybrid duplex. Org. Biomol. Chem., 2018, 16(24), 4424-4428.
[http://dx.doi.org/10.1039/C7OB02709E] [PMID: PMID: 29498732]
[40]
Sirajuddin, M.; Ali, S.; Badshah, A. Drug-DNA interactions and their study by UV-Visible, fluorescence spectroscopies and cyclic voltametry. J. Photochem. Photobiol. B, 2013, 124, 1-19.
[http://dx.doi.org/10.1016/j.jphotobiol.2013.03.013] [PMID: PMID: 23648795]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 8
Year: 2020
Published on: 13 July, 2020
Page: [671 - 678]
Pages: 8
DOI: 10.2174/1570179417666200713181959
Price: $65

Article Metrics

PDF: 25
HTML: 2